Consolidated Statement of Changes in Shareholders’ Equity (Deficit) - USD ($)	Common Stock	Preferred Stock	Common Stock Issuable	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2018	$ 8,518		$ 26,137	$ 7,531,553	$ (10,501,055)	$ (2,934,847)
Balance (in Shares) at Dec. 31, 2018	85,178,902
Balance at Dec. 31, 2019	$ 10,990		159,538	13,016,446	(16,029,654)	(2,842,680)
Balance (in Shares) at Dec. 31, 2019	109,894,490
Acquisition of Hughes Center for Functional Medicine	$ 397			999,603		1,000,000
Acquisition of Hughes Center for Functional Medicine (in Shares)	3,968,254
Sales of common stock	$ 832		59,000	1,444,504		1,504,336
Sales of common stock (in Shares)	8,313,992
Fair value of warrants allocated to proceeds of common stock				154,650		154,650
Shares issued with convertible notes payable	$ 14			28,303		28,317
Shares issued with convertible notes payable (in Shares)	140,500
Fair value of warrants allocated to proceeds of convertible notes payable				225,323		225,323
Fair value of warrants issued and modifications of beneficial conversion feature to extend convertible notes payable				1,046,399		1,046,399
Conversion of convertible notes payable to common stock	$ 633			1,218,922		1,219,555
Conversion of convertible notes payable to common stock (in Shares)	6,332,893
Fair value of warrants issued for professional services				54,257		54,257
Consultant and director fees payable with common shares and warrants	$ 56		67,240	108,026		175,322
Consultant and director fees payable with common shares and warrants (in Shares)	560,000
Shares and options issued pursuant to employee equity incentive plan	$ 35		7,161	206,336		213,532
Shares and options issued pursuant to employee equity incentive plan (in Shares)	349,063
Exercise of stock options	$ 11			(11)		0
Exercise of stock options (in Shares)	113,141
Exercise of stock warrants	$ 494			(219)		$ 275
Exercise of stock warrants (in Shares)	4,937,745					154,166
Repurchase of treasury stock				(1,200)		$ (1,200)
Net loss					(5,528,599)	(5,528,599)
Balance at Dec. 31, 2020	$ 18,797	$ 2,750	262,273	22,851,098	(21,784,910)	1,350,008
Balance (in Shares) at Dec. 31, 2020	187,967,881	2,750,000
Sales of common stock	$ 1,327		(59,000)	1,058,684		1,001,011
Sales of common stock (in Shares)	13,264,262
Fair value of warrants allocated to proceeds of common stock				186,275		186,275
Sale of common and preferred stock in exchange for marketable securities	$ 2,452	$ 2,750		3,061,687		3,066,889
Sale of common and preferred stock in exchange for marketable securities (in Shares)	24,522,727	2,750,000
Conversion of convertible notes payable to common stock	$ 1,420			1,664,096		1,665,516
Conversion of convertible notes payable to common stock (in Shares)	14,197,123
Gain on extinguishment of related party debt allocated to additional paid in capital				283,862		283,862
Acquisition of Cura Health Management LLC	$ 224			201,451		201,675
Acquisition of Cura Health Management LLC (in Shares)	2,240,838
Acquisition of MedOffice Direct LLC	$ 1,904			2,702,565		2,704,469
Acquisition of MedOffice Direct LLC (in Shares)	19,045,564
Contingent acquisition consideration issued	$ 184			292,599		292,783
Contingent acquisition consideration issued (in Shares)	1,835,626
Consultant and director fees payable with common shares and warrants	$ 111		153,940	159,817		313,868
Consultant and director fees payable with common shares and warrants (in Shares)	1,114,861
Shares and options issued pursuant to employee equity incentive plan	$ 92		7,795	223,709		231,596
Shares and options issued pursuant to employee equity incentive plan (in Shares)	924,992
Exercise of stock warrants	$ 93			(93)
Exercise of stock warrants (in Shares)	927,398
Net loss					$ (5,755,256)	$ (5,755,256)